Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report) reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $61.58 and last traded at $61.58, with a volume of 4017 shares. The stock had previously closed at $55.91.
Analysts Set New Price Targets
Separately, Royal Bank Of Canada raised shares of Sandoz Group from a "hold" rating to a "moderate buy" rating in a report on Friday, May 2nd.
Get Our Latest Stock Analysis on Sandoz Group
Sandoz Group Price Performance
The company has a debt-to-equity ratio of 0.57, a current ratio of 1.24 and a quick ratio of 0.79. The stock's fifty day simple moving average is $55.44 and its 200-day simple moving average is $48.23.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Further Reading
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access